Hyperleptinemia elicited by the 5-HT precursor, 5-hydroxytryptophan in mice: Involvement of insulin

Life Sciences

Volumn 73, Issue 18, 2003, Pages 2335-2344

  Yamada, Jun ^a   Sugimoto, Yumi ^a   Ujikawa, Masanori ^a   Goko, Hideki ^b   Yagura, Tatsuo ^c  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KWANSEI GAKUIN UNIVERSITY   (Japan)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); 5 Hydroxytryptophan (5 HTP); Insulin; Leptin; Streptozotocin

Indexed keywords

5 HYDROXYTRYPTOPHAN; INSULIN; LEPTIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERLEPTINEMIA; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

EID: 0043198266     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00641-6     Document Type: Article

References (24)

1. Blundell J.E. Serotonin and appetite. Neuropharmacology. 23(12B):1984;1537-1551.
2. Campfield M.A., Smith F.J., Gulsez Y., Devos R., Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 269(5223):1995;546-549.
3. Fruhbeck G., Jebb S.A., Prentice A.M. Leptin: physiology and pathophysiology. Clinical Physiology. 18(5):1998;399-419.
4. Furman B.L., Wilson G.A. Further studies on the effects of 5-hydroxytryptophan on plasma glucose and insulin in the mouse. Diabetologia. 19(14):1980;386-390.
5. 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology. 137(9):1996;4054-4057.
6. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269(5223):1995;543-546.
7. Hardie L.J., Rayner D.V., Holmes S., Trayhurn P. Circulating leptin levels are modulated by fasting, cold exposure, and insulin administration in lean but not Zucker(fa/fa) rats as measured by ELISA. Biochemical and Biophysical Research Communications. 223(3):1996;660-665.
8. Havel P.J., Uriu-Hare J.Y., Liu T., Stanhope K.L., Stern J.S., Keen C.L., Ahren B. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. American Journal of Physiology. 274(5 Pt 2):1998;R1482-R1491.
9. Jacoby J.H., Bryce G.F. Monoaminergic modulation of pancreatic endocrine secretion. General Pharmacology. 9(6):1978;411-419.
10. Kirchgessner T.G., Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Tumor necrosis factor-a contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. Journal of Clinical Investigation. 100(11):1997;2777-2782.
11. Koopmans S.J., Frolich M., Gribnau E.H., Westendrop R.G., DeFronzo R.A. Effect of hyperinsulinemia on plasma leptin concentrations and food intake in rats. American Journal of Physiology. 274(6 part 1):1998;E998-E1001.
12. Leroy P., Dessolin S., Villageois P., Moon B.C., Friedman J.M., Ailhaud G., Dani C. Expression of ob gene in adipose cells: Regulation by insulin. Journal of Biological Chemistry. 271(5):1996;2365-2368.
13. Mastronardi C.A., Walczewska A., Yu W.H., Karanth S., Parlow A.F., MacCann S.M. The possible role of prolactin in the circadian rhythm of leptin secretion in male rats. Proceedings Society for Experimental Biology and Medicine. 224(3):2000;152-158.
14. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269(5223):1995;540-543.
15. Rayner D.V., Simon E., Duncan J.S., Trayhurn P. Hyperleptinaemia in mice induced by administration of tyrosine hydroxylase inhibitor α-methyl-p-tyrosine. FEBS Letters. 429(3):1998;395-398.
16. Saladin R., De Vos P., Guerre-Millo M., Leturque A., Girard J., Stales G., Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature. 377(6549):1995;527-529.
17. Sarraf P., Frederich R.C., Turner E.M., Ma G., Jaskowiak N.T., Rivet D.J. III, Flier J.S., Lowel B.B., Fraker D.L., Alexander H.R. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. Journal of Experimental Medicine. 185(1):1997;171-175.
18. Sugimoto Y., Kimura I., Yamada J., Watanabe Y., Takeuchi N., Horisaka K. Effects of serotonin on blood glucose and insulin levels of glucose- and streptozotocin-treated mice. Japanese Journal of Pharmacology. 54(1):1990;93-96.
19. Trayhurn P., Duncan J.S., Rayner D.V. Acute cold-induced suppression of ob(obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochemical Journal. 311(Part 3):1995;729-733.
20. 3-adrenoceptor agonists BRL 35135A and ZD2079. Biochemical and Biophysical Research Communications. 228(2):1996;605-610.
21. Van de Kar L.D. Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annual Reviews of Pharmacology and Toxicology. 31:1991;289-320.
22. Yamada J., Sugimoto Y., Kimura I., Takeuchi N., Horiska K. Serotonin-induced hypoglycemia and increased serum insulin levels. Life Sciences. 45(20):1989;1931-1936.
23. Yamada J., Sugimoto Y., Ujikawa M. The serotonin precursor 5-hydroxytryptophan elevates serum leptin levels in mice. European Journal of Pharmacology. 383(1):1999;49-51.
24. Yamada J., Ujikawa M., Sugimoto Y. Serum leptin levels after central and systemic injection of a serotonin precursor, 5-hydroxytryptophan, in mice. European Journal of Pharmacology. 406(1):2000;159-162.